Les protocoles (phases précoces) du Centre Paul STRAUSS

TINIVO

Essai de phase 1b/2, multicentrique, en ouvert, évaluant un traitement par Tivozanib administré en asscociation avec Nivolumab chez des patients atteints de cancer du rein métastatique

Prostate

Rein

Vessie

TRAP

A phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications

CA209-9GW

Phase 1/2 study to evaluate the safety and preliminary efficacy of Nivolumab combined with Daratumumab in participants with advanced or metastatic solid tumors

UNITE DE RECHERCHE CLINIQUE
Tél 03 88 25 24 85
recherche-clinique@strasbourg.unicancer.fr